Carregant...
LC-MS/MS assay for the quantitation of the HDAC inhibitor belinostat and five major metabolites in human plasma
The histone deacetylase inhibitor belinostat is being evaluated clinically as a single agent in the treatment of Peripheral T-cell lymphomas and in combination with other anticancer agents to treat a wide range of human cancers including acute leukemias and solid tumors. To determine the pharmacokin...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3663884/ https://ncbi.nlm.nih.gov/pubmed/23644904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2013.03.025 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|